You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
漢港控股(01663.HK)擴大分析及檢測平台協助抗疫藥物研發
格隆匯 02-03 21:37

格隆匯2月3日丨漢港控股(01663.HK)發佈公告,公司旗下子公司浙江美測醫藥科技有限公司一直以打造世界一流藥物外包研發服務平台為宗旨,自成立以來已為國內近百家藥企及研發機構提供外包研發服務。浙江美測擁有可用於蛋白質解析的高分辨時間飛行二級質譜,用於代謝樣本分析的AB-SciexMS/MS質譜平台,用於大分子糖類解析的離子色譜╱高分辨質譜平台,用於細胞表位解析的流式細胞儀分析及檢測平台以及可用於進行微生物限度及無菌檢測等現代藥學及基礎醫學實驗平台。

此等平台皆可用作針對新型冠狀病毒藥物及疫苗的研發,從而助力國家的抗疫工作。浙江美測將加大此等平台相關的硬件、軟件、人材及技術研發投入,以協助藥企及研發機構的研發。

再者,浙江美測持續在實驗室合規性建設上不遺餘力,並正在完成申請二級生物安全實驗室及國內CNAS認證的過程中。同時,浙江美測正在積極爭取早日觸發並通過美國FDA審計。

另外,公司旗下子公司江西港洪實業有限公司向宜春市公安局捐贈人民幣30萬物資,包括防護手套、防護服及防護口罩等以支持政府防控疫情,短期應付漸趨嚴峻的疫情。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account